Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

Jason J Luke; Diwakar Davar; Robert H Andtbacka; Nina Bhardwaj; Joshua D Brody; Jason Chesney; Robert Coffin; Thierry de Baere; Tanja D de Gruijl; Matthew Fury; Gregory Goldmacher; Kevin J Harrington; Howard Kaufman; Ciara M Kelly; Anuradha D Khilnani; Ke Liu; Sherene Loi; Georgina V Long; Ignacio Melero; Mark Middleton; Bart Neyns; David J Pinato; Rahul A Sheth; Stephen B Solomon; Philippe Szapary; Aurelien Marabelle

doi:10.1136/jitc-2023-008378

Article info

Position article and guidelines

Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

Authors

Jason J Luke UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA PubMed articles Google scholar articles
Diwakar Davar UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA PubMed articles Google scholar articles
Robert H Andtbacka HiFiBiO Therapeutics, Cambridge, Massachusetts, USA PubMed articles Google scholar articles
Nina Bhardwaj Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Joshua D Brody Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Jason Chesney James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA PubMed articles Google scholar articles
Robert Coffin Replimune Inc, Woburn, Massachusetts, USA PubMed articles Google scholar articles
Thierry de Baere Center for Biotherapies In Situ (BIOTHERIS), INSERM CIC1428, Interventional Radiology Unit, Department of Medical Imaging, Gustave Roussy Cancer Center, University of Paris Saclay, Villejuif, France PubMed articles Google scholar articles
Tanja D de Gruijl Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands Cancer Immunology, Amsterdam Institute for Infection and Immunology, Amsterdam, Netherlands PubMed articles Google scholar articles
Matthew Fury Oncology Clinical Development, Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA PubMed articles Google scholar articles
Gregory Goldmacher Merck & Co Inc, Rahway, New Jersey, USA PubMed articles Google scholar articles
Kevin J Harrington The Institute of Cancer Research, The Royal Marsden National Institute for Health and Care Research Biomedical Research Centre, London, UK PubMed articles Google scholar articles
Howard Kaufman Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA Ankyra Therapeutics, Boston, Massachusetts, USA PubMed articles Google scholar articles
Ciara M Kelly Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articles Google scholar articles
Anuradha D Khilnani Merck & Co Inc, Rahway, New Jersey, USA PubMed articles Google scholar articles
Ke Liu Marengo Therapeutics, Inc, Cambridge, Massachusetts, USA PubMed articles Google scholar articles
Sherene Loi Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Georgina V Long Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, New South Wales, Australia PubMed articles Google scholar articles
Ignacio Melero CIMA, Universidad de Navarra, Pamplona, Spain PubMed articles Google scholar articles
Mark Middleton Department of Oncology, University of Oxford, Oxford, UK PubMed articles Google scholar articles
Bart Neyns Department of Medical Oncology, Universitair Ziekenhuis Brussel, Jette, Belgium PubMed articles Google scholar articles
David J Pinato Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy PubMed articles Google scholar articles
Rahul A Sheth Department of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articles Google scholar articles
Stephen B Solomon Chief of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA Professor of Radiology, Weill Cornell Medical College, New York, New York, USA PubMed articles Google scholar articles
Philippe Szapary Interventional Oncology, Johnson & Johnson, New Brunswick, New Jersey, USA PubMed articles Google scholar articles
Aurelien Marabelle Center for Biotherapies In Situ (BIOTHERIS), INSERM CIC1428, Department for Therapeutic Innovation and Early Phase Trials (DITEP), Gustave Roussy Cancer Center, University of Paris Saclay, Villejuif, France PubMed articles Google scholar articles

Citation

Luke JJ, Davar D, Andtbacka RH, et al

Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

Journal for ImmunoTherapy of Cancer 2024;12:e008378. doi: 10.1136/jitc-2023-008378

Online issue publication

April 18, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password